胸主动脉腔内修复术治疗B型主动脉夹层时左锁骨下动脉的处理
该系统综述检索PubMed和MEDLINE至2020年10月,纳入26项研究共1483例接受TEVAR的B型主动脉夹层患者,左锁骨下动脉覆盖率47.7%,覆盖未显著增加卒中风险(P=.0815),但覆盖后未行血运重建者卒中比例更高(P=.0478),作者建议始终推荐左锁骨下动脉血运重建。
要点
- 左锁骨下动脉覆盖率为47.7%(707/1483),未显著增加卒中风险(P=.0815)。
- 覆盖左锁骨下动脉后,未行血运重建者卒中比例4.8%(5/105)高于血运重建者1%(2/203)(P=.0478)。
- 作者建议对左锁骨下动脉覆盖患者始终推荐血运重建。
核心结论
- 系统综述显示,在复杂B型主动脉夹层腔内修复中覆盖左锁骨下动脉未显著增加神经系统并发症风险,但作者建议始终推荐左锁骨下动脉血运重建。
研究设计与样本
- 系统综述,检索PubMed和MEDLINE数据库至2020年10月,纳入26项报告(24项回顾性研究和2项前瞻性研究),共1483例接受TEVAR的B型主动脉夹层患者,平均年龄56.9±6.2岁。
主要发现
- 1483例中急性932例(62.9%)、亚急性36例(2.4%)、慢性515例(34.7%),技术成功率97.8%,院内死亡率4.9%。
- 左锁骨下动脉起始部覆盖707例(47.7%),其中326例行左锁骨下动脉血运重建(外科96例、腔内170例、未指明或未报告60例)。
- 左锁骨下动脉血运重建中,同期68.1%、TEVAR术后1.8%、未报告30.1%。
- 1146例中左臂跛行10例(0.9%);总体卒中率3.3%,左锁骨下动脉覆盖组2.7% vs 未覆盖组1%(P=.0815)。
- 覆盖左锁骨下动脉的卒中患者中,血运重建者1%(2/203)vs 未血运重建者4.8%(5/105)(P=.0478);截瘫26例(1.9%),覆盖组0.7%(3/433)vs 未覆盖组1.4%(7/491)(P=.3508),16例未报告。
关键数值与推荐
- 左锁骨下动脉覆盖未显著增加卒中风险(P=.0815),但覆盖后未行血运重建者卒中比例显著高于血运重建者(P=.0478)。
- 平均随访32.1±25.6个月,内漏138例(13.4%)。
临床怎么用
- 作者建议在TEVAR治疗复杂B型主动脉夹层覆盖左锁骨下动脉时,始终推荐行左锁骨下动脉血运重建。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) has been the favored approach for the treatment of type B aortic dissection (TBAD). To obtain an adequate proximal landing zone, coverage of the left subclavian artery (LSA) will often be necessary. The occurrence of possible neurologic complications has continued to be debated. We investigated the management of the LSA in patients with TBAD undergoing endovascular repair. METHODS: We searched the PubMed and MEDLINE databases to October 2020 for studies of TEVAR for TBAD. Data on the study design, demographics, endograft details, LSA coverage and revascularization, mortality, complications, and follow-up were extracted and analyzed. The effects of LSA coverage and revascularization on neurologic complications and outcomes were investigated. RESULTS: A total of 26 reports (24 retrospective and 2 prospective) were deemed eligible for our study. A total of 1483 patients (mean age, 56.9 ± 6.2 years) had undergone TEVAR for acute (n = 932; 62.9%), subacute (n = 36; 2.4%), or chronic (n = 515; 34.7%) TBAD, with a success rate of 97.8% and hospital mortality of 4.9%. The LSA origin had been covered for 707 patients (47.7%), and 326 had undergone LSA revascularization (surgical, n = 96; endovascular, n = 170; unspecified or not reported, n = 60). LSA revascularization was concomitant for 68.1% of cases, after TEVAR for 1.8%, and not reported for 30.1%. Of 1146 patients, 10 (0.9%) had experienced left arm claudication, and the overall stroke rate was 3.3% (2.7% for the LSA group and 1% for the uncovered LSA group; P = .0815). Of the patients with stroke and a covered LSA, 1% (2 of 203) had undergone LSA revascularization and 4.8% (5 of 105) had not (P = .0478). Twenty-six patients (1.9%) had developed paraplegia: 0.7% (3 of 433) with a covered LSA, 1.4% (7 of 491) with an uncovered LSA (P = .3508), and not reported for 16 patients. Endoleak was present in 138 patients (13.4%) at a mean follow-up of 32.1 ± 25.6 months. CONCLUSIONS: Our review has shown that LSA coverage during endovascular repair for complicated TBAD will does not significantly increase the risk of neurologic complications; however, revascularization of the LSA should be always recommended.
引用
- Wang C, Pozzoli A, von Segesser LK, et al. Management of left subclavian artery in type B aortic dissection treated with thoracic endovascular aorta repair. J Vasc Surg. 2022. PMID: 36272506. doi:10.1016/j.jvs.2022.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。